Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
DC Funds, LP (CIK 1869028) reported $1.3M across 3 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: TCRX ($617,463, 49.27%), BRNS ($423,855, 33.82%), HOWL ($212,018, 16.92%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TCRX | TSCAN THERAPEUTICS INC | $617,463 | 49.27% | 630,000 | Hold |
| 2 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $423,855 | 33.82% | 642,204 | Hold |
| 3 | HOWL | WEREWOLF THERAPEUTICS INC | $212,018 | 16.92% | 589,102 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30